Home Vitamin A and vitamin D3 protect the visual apparatus during the development of dopamine-2 receptor knockout mouse model of Parkinsonism
Article
Licensed
Unlicensed Requires Authentication

Vitamin A and vitamin D3 protect the visual apparatus during the development of dopamine-2 receptor knockout mouse model of Parkinsonism

  • Mujittapha Sirajo Umar EMAIL logo and Badamasi Muhammed Ibrahim
Published/Copyright: June 15, 2023

Abstract

Objectives

Dopamine-related movement disorders are associated with a loss of visual acuity. Studies have shown that chemical stimulation of the vitamin D3 receptor (VDR) ameliorates movement disorders; however, the chemical stimulation is not effective when there is a deficiency of vitamin A in the cells. In the study, we examine the role of VDR and its interplay with vitamin A in impaired visual function in the dopamine deficit model.

Methods

Thirty (30) male mice with an average weight of 26 g ± (2) were divided into six group (NS,−D2,−D2 + VD D2 + VD, −D2 + VA, −D2 + (VD + VA) and −D2 + D2 groups). Dopamine deficit models of movement disorders were created using 15 mg/kg of haloperidol (−D2) injected intraperitoneally daily for 21 days. In the −D2 + (VD + VA) group, 800 IU/day of vitamin D3 (VD) and 1000 IU/day of vitamin A were concurrently used, while in the −D2 + D2 group, bromocriptine (+D2) was used as the standard treatment of the model. At the end of the treatment phase, the animals were subjected to visual water box test for visual acuity. The level of oxidative stress was measured using Superoxide dismutase (SOD) and malondialdehyde (MDA) in the retina and visual cortex. The level of cytotoxicity in these tissues was measured using Lactate dehydrogenase (LDH) assay, while the structural integrity of these tissues was assessed using a light microscope by assessing slide mounted sections that were stained with haematoxylin and eosin.

Results

A significant decline in time taken to reach the escape platform in the visual water box test was observed in the −D2 (p<0.005) and −D2 + D2 (p<0.05) group. In the retina and the visual cortex, a significant increase in LDH, MDA and the density of degenerating neurons was observed in the −D2 and −D2 + D2 groups. LDH level in the retina was also found to be significantly increased in (−D2 + VD, −D2 + VA, −D2 + (VD + VA). A Significant decrease in SOD was found in the retina and visual cortex of −D2 and −D2 + D2 group. In the histology of the retina, thinning of the retina, retinal fold, distortion and retinal detachment were all seen in the −D2 group. These structural alterations were not seen in other groups. Histological hallmarks of degeneration were observed in the visual cortex of the mice from the −D2 (p<0.001), −D2 + D2 (p<0.005) and −D2 + VD (p<0.05) groups only.

Conclusions

Dopamine-deficient models of movement disorders are associated with loss of visual functions, especially due to thinning of the retina, retinal fold, retinal detachment, and neurodegeneration in the visual cortex. Supplementation during the development of the model with vitamin D3 and vitamin A prevented the deterioration of the retina and visual cortex by reducing the degree of oxidative stress and cytotoxicity.


Corresponding author: Mujittapha Sirajo Umar, M.Sc, Skyline University, Room 06, 2nd floor School of Basic and Medical Sciences (SBMS), Kano, Nigeria; and Bayero University Kano, Kano, Nigeria, Phone: +2348101682449, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review. [Protocol Number: BUK/ANA 0326.].

References

1. Shen, AL, Moran, SM, Glover, EA, Teixeira, LB, Bradfield, CA. Retinal pathology in the PPCD1 mouse. PLoS One 2017;12:8–10. https://doi.org/10.1371/journal.pone.0185094.Search in Google Scholar PubMed PubMed Central

2. Archibald, NK, Clarke, MP, UP, M, Burn, DJ. The retina in Parkinson’s disease. Brain 2009;132:1128–45. https://doi.org/10.1093/brain/awp068.Search in Google Scholar PubMed

3. Lee, JY, Ahn, J, Shin, JY, Jeon, B. Parafoveal change and dopamine loss in the retina with Parkinson’s disease. Ann Neurol 2021;89:421–2. https://doi.org/10.1002/ana.25972.Search in Google Scholar PubMed

4. Galvan, A, Wichmann, T. Pathophysiology of parkinsonism. Clin Neurophysiol 2008;119:1459–74. https://doi.org/10.1016/j.clinph.2008.03.017.Search in Google Scholar PubMed PubMed Central

5. Denis, P, Nordmann, J, Elena, P, Dussaillant, M, Saraux, H, Lapalus, P. Physiological roles of dopamine and neuropeptides in the retina. Fundam Clin Pharmacol 1993;7:293–304. https://doi.org/10.1111/j.1472-8206.1993.tb00243.x.Search in Google Scholar PubMed

6. Korshunov, KS, Blakemore, LJ, Trombley, PQ. Illuminating and sniffing out the neuromodulatory roles of dopamine in the retina and olfactory bulb. Front Cell Neurosci 2020;14:275. https://doi.org/10.3389/fncel.2020.00275.Search in Google Scholar PubMed PubMed Central

7. Abd-Elmagid, BF, Al-Ghamdi, FA. Changes induces by haloperidol (antidepressant drug) on the developing retina of the chick embryo. Saudi J Biol Sci 2009;16:85–94. https://doi.org/10.1016/j.sjbs.2009.10.006.Search in Google Scholar PubMed PubMed Central

8. Schaeffer, E, Berg, D. Dopaminergic therapies for non-motor symptoms in Parkinson ’ s disease. CNS Drugs 2017;10:551–70. https://doi.org/10.1007/s40263-017-0450-z.Search in Google Scholar PubMed

9. Samani, NN, Proudlock, FA, Siram, V, Suraweera, C, Hutchinson, C, Nelson, CP, et al.. Retinal layer abnormalities as biomarkers of schizophrenia. Schizophr Bull 2018;44:876–85. https://doi.org/10.1093/schbul/sbx130.Search in Google Scholar PubMed PubMed Central

10. Shin, H, Chung, J. Drug-induced parkinsonism epidemiology of drug-induced etiology of drug-induced parkinsonism. J Clin Neurol 2012;8:15–21. https://doi.org/10.3988/jcn.2012.8.1.15.Search in Google Scholar PubMed PubMed Central

11. Ming, W, Palidis, DJ, Spering, M, Mckeown, MJ. Visual contrast sensitivity in early-stage Parkinson ’ s disease. Invest Ophthalmol Vis Sci 2016;57:5696–704. https://doi.org/10.1167/iovs.16-20025.Search in Google Scholar PubMed

12. Armstrong, RA. Visual dysfunction in Parkinson’s disease In: Non-motor Parkinson’s: management and hidden face of related disorders, 1st ed. Birmingham, United Kingdom: Elsevier Inc.; 2017, vol 134:921–46 pp.10.1016/bs.irn.2017.04.007Search in Google Scholar PubMed

13. Sondereker, KB, Stabio, ME, Jamil, JR, Tarchick, MJ, Renna, JM. Where you cut matters : a dissection and analysis guide for the spatial orientation of the mouse retina from ocular landmarks. J Vis Exp 2018;8:1–11. https://doi.org/10.3791/57861-v.Search in Google Scholar

14. Seppi, K, Chaudhuri, KR, Coelho, M, Fox, SH, Uk, M, Katzenschlager, R, et al.. Update on treatments for nonmotor symptoms of Parkinson’s disease — an evidence-based medicine review. 2019;18:1–19.Search in Google Scholar

15. Bankole, OO, Laoye, BJ, Sirjao, MU, Ishola, AO, Oyeleke, DE, Balogun, WG, et al.. Vitamin D 3 receptor activation rescued corticostriatal neural activity and improved motor function in – D 2 R tardive dyskinesia mice model. J Biomed Sci Eng 2015;8:520–30. https://doi.org/10.4236/jbise.2015.88049.Search in Google Scholar

16. Cui, X, Pelekanos, M, Liu, P, Burne, THJ, Mcgrath, JJ, Eyles, DW. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat. Neuroscience 2013;236:77–87. https://doi.org/10.1016/j.neuroscience.2013.01.035.Search in Google Scholar PubMed

17. Keeney, JTR, Förster, S, Sultana, R, Brewer, LD, Latimer, CS, Cai, J, et al.. Free Radical Biology and Medicine Dietary vitamin D de fi ciency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain : implications for low vitamin D-dependent age-related cognitive. Free Radic Biol Med 2013;65:324–34. https://doi.org/10.1016/j.freeradbiomed.2013.07.019.Search in Google Scholar PubMed PubMed Central

18. Syal, K, Srinivasan, ADB. Levels in PBMCs VDR, RXR, coronin-1 and interferon + I of type-2 diabetes patients : molecular link between diabetes and tuberculosis. Indian J Clin Biochem 2014;7:323–8.10.1007/s12291-014-0431-7Search in Google Scholar PubMed PubMed Central

19. Percário, S, Barbosa, S, Luiz, E, Varela, P, Rafael, A, Gomes, Q, et al.. Review article oxidative stress in Parkinson’s disease: potential benefits of antioxidant supplementation. Oxid Med Cell Longev 2020;20:23.10.1155/2020/2360872Search in Google Scholar PubMed PubMed Central

20. Lin, Y, Jones, BW, Liu, A, Tucker, JF, Rapp, K, Luo, L, et al.. Retinoid receptors trigger neuritogenesis in retinal degenerations. Faseb J 2012;26:81–92. https://doi.org/10.1096/fj.11-192914.Search in Google Scholar PubMed PubMed Central

21. Prusky, GT, West, PWR, Douglas, RM. Behavioral assessment of visual acuity in mice and rats. Vis Res 2000;40:2201–9. https://doi.org/10.1016/s0042-6989(00)00081-x.Search in Google Scholar PubMed

22. Trist, BG, Hare, DJ, Double, KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell 2019;18:1–23. https://doi.org/10.1111/acel.13031.Search in Google Scholar PubMed PubMed Central

23. Khan, AA, Allemailem, KS, Alhumaydhi, FA, Sivakumar, JT. The biochemical and clinical perspectives of lactate dehydrogenase: an enzyme of active metabolism the biochemical and clinical perspectives of lactate dehydrogenase: an enzyme of active metabolism. Endocr Metab Immune Disord – Drug Targets 2021;20:030.10.2174/1871530320666191230141110Search in Google Scholar PubMed

24. Zhu, J, Xiong, Y, Zhang, Y, Wen, J, Cai, N, Cheng, K, et al.. Review article the molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxid Med Cell Longev 2020;20:14.10.1155/2020/8810785Search in Google Scholar PubMed PubMed Central

25. Niedzielska, E, Smaga, I, Gawlik, M, Moniczewski, A, Stankowicz, P, Pera, J, et al.. Oxidative stress in neurodegenerative diseases. Mol Neurobiol 2015;1:11–7. https://doi.org/10.1007/s12035-015-9337-5.Search in Google Scholar PubMed PubMed Central

26. Mujittapha, SU, Kauthar, M, Azeez, IO, Oyem, JC. Ascorbic acid improves extrapyramidal syndromes and corpus striatal degeneration induced by dopamine-2 receptor inhibition in Wistar rats. Drug Metab Pers Ther 2020;36:47–52. https://doi.org/10.1515/dmdi-2020-0137.Search in Google Scholar PubMed

27. Sirajo, MU, Owolabi, LF, Abubakar, M, Saleh, SM, Shehu, K, Oyeleke, EO. Proposed neuromorphological mechanism of dopamine-2 receptor blocker model of parkinsonism. Niger J Neurosci 2020;11:21–7. https://doi.org/10.47081/njn2020.11.1/003.Search in Google Scholar

28. Cayouette, M. Retinal cell and tissue culture. Nat Neurosci 2017;10:45–50.Search in Google Scholar

29. Dorman, D. Extrapyramidal system neurotoxicity: animal models. Occup Neurol 2015;131:207–23.10.1016/B978-0-444-62627-1.00012-3Search in Google Scholar PubMed

30. Masland, RH. The fundamental plan of the retina. Nat Neurosci 2001;4:877–86. https://doi.org/10.1038/nn0901-877.Search in Google Scholar PubMed

31. Rei, AN, Chervenak, AP, Dolikian, ME, Benenati, BA, Meyers, BS, Demertzis, ZD, et al.. The rat retina has fi ve types of ganglion-cell photoreceptors. Exp Eye Res 2015;130:17–28. https://doi.org/10.1016/j.exer.2014.11.010.Search in Google Scholar PubMed PubMed Central

32. Mcknight, S, Hack, N. Tox in - Induced Parkinsonism. Neurol Clin NA 2020;38:853–65. https://doi.org/10.1016/j.ncl.2020.08.003.Search in Google Scholar PubMed

33. Armstrong, RA. Oculo-visual dysfunction in Parkinson’s disease. J Park Dis 2015;5:715–26. https://doi.org/10.3233/jpd-150686.Search in Google Scholar PubMed PubMed Central

34. Ke, C, Yang, F, Wu, W, Chung, C, Lee, R, Yang, W, et al.. Vitamin D 3 reduces tissue damage and oxidative stress caused by exhaustive exercise. Int J Med Sci 2016;13:147–53. https://doi.org/10.7150/ijms.13746.Search in Google Scholar PubMed PubMed Central

35. Alkhatib, AJ, Abduallah, N, Alrakaf, M. Lactate dehydrogenase: physiological roles and clinical implications. Am J Biomed Sci Res 2019;3:415–6. https://doi.org/10.34297/ajbsr.2019.03.000705.Search in Google Scholar

36. Guiney, SJ, Adlard, PA, Bush, AI, Finkelstein, DI, Ayton, S. Neurochemistry international ferroptosis and cell death mechanisms in Parkinson’s disease. Neurochem Int 2017;104:34–48. https://doi.org/10.1016/j.neuint.2017.01.004.Search in Google Scholar PubMed

37. Michel, PP, Hirsch, EC, Hunot, S. Review understanding dopaminergic cell death pathways in Parkinson disease. Neuron Rev 2016;18:675–91. https://doi.org/10.1016/j.neuron.2016.03.038.Search in Google Scholar PubMed

38. Press, H, York, N, Nw, A. Programmed cell death in neuronal developement. Science 2014;39:20.Search in Google Scholar

39. Levy, OA, Malagelada, C, Lloyd, A. Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009;14:478–500. https://doi.org/10.1007/s10495-008-0309-3.Search in Google Scholar PubMed PubMed Central

40. Jiang, T, Sun, Q, Chen, S. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol 2016;10:20–7. https://doi.org/10.1016/j.pneurobio.2016.07.005.Search in Google Scholar PubMed

41. Fricker, M, Tolkovsky, AM, Borutaite, V, Coleman, M, Brown, GC, Fricker, M, et al.. Neuronal cell death. Physiol Rev 2019;98:813–80. https://doi.org/10.1152/physrev.00011.2017.Search in Google Scholar PubMed PubMed Central

42. Hirsch, EC, Hunot, S. Neuroinfl ammation in Parkinson’s disease: a target for neuroprotection. Lancet Neurol 2009;8:382–97. https://doi.org/10.1016/s1474-4422(09)70062-6.Search in Google Scholar PubMed

43. Tamara, Gardner, D, Addington, D, Martino, D, Morgante, F, Ricciardi, L, et al.. The assessment and treatment of akathesia. Can J Psychiatr 2018;63:719–29. https://doi.org/10.1177/0706743718760288.Search in Google Scholar PubMed PubMed Central

44. Hayes, MT. Parkinson’s disease and parkinsonism. Am J Med 2019;132:802–7. https://doi.org/10.1016/j.amjmed.2019.03.001.Search in Google Scholar PubMed

45. Keener, AM, Bordelon, YM. Parkinsonism. Semin Neurol 2016;36:330–4. https://doi.org/10.1055/s-0036-1585097.Search in Google Scholar PubMed

46. Caravaggio, F, Scifo, E, Sibille, EL, Mota, SEH, Gerretsen, P, Remington, G, et al.. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. Exp Eye Res 2018;175:32–41. https://doi.org/10.1016/j.exer.2018.06.006.Search in Google Scholar PubMed PubMed Central

47. Jin, CJ, Yu, SH, Wang, X, Woo, SJ, Park, HJ, Lee, HC. The effect of lithospermic acid, an antioxidant, on development of diabetic the effect of lithospermic acid, an antioxidant, on development of diabetic retinopathy in spontaneously obese diabetic rats. PLoS One 2014;9:e08232.10.1371/journal.pone.0098232Search in Google Scholar PubMed PubMed Central

48. Kurose, T, Sugano, E, Sugai, A, Shiraiwa, R, Kato, M, Mitsuguchi, Y, et al.. Neuroprotective effect of a dietary supplement against glutamate-induced excitotoxicity in retina. Int J Ophthalmol 2019;12:1231–7. https://doi.org/10.18240/ijo.2019.08.01.Search in Google Scholar PubMed PubMed Central

49. Ramirez, AI, Hoz, RD, Salobrar-garcia, E, Salazar, JJ. The role of microglia in retinal neurodegeneration: alzheimer’s disease, Parkinson, and glaucoma. Front Aging Neurosci 2017;9:1–21.10.3389/fnagi.2017.00214Search in Google Scholar PubMed PubMed Central

Received: 2023-02-28
Accepted: 2023-05-19
Published Online: 2023-06-15

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. The effect of lavender on mothers sleep quality in the postpartum period: a systematic review and meta-analysis
  4. The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis
  5. Neuroprotective potential of Celastrus paniculatus seeds against common neurological ailments: a narrative review
  6. Intuitive and mindful eating to improve physiological health parameters: a short narrative review of intervention studies
  7. Research Articles
  8. Vitamin C supplementation modulates crude oil contaminated water induced gravid uterine impaired contractile mechanism and foetal outcomes in Wistar rats
  9. Acute and sub acute toxicity of Amirdha Gandhi Kukkil Vallathy an effective Siddha herbo mineral formulation used in the treatment of rheumatoid arthritis in wistar albino rat model
  10. Anti-hyperplastic effects of the Dacryodes edulis (Burseraceae) leaves aqueous extract on tamoxifen-induced endometrium hyperplasia on Wistar rat
  11. Vitamin A and vitamin D3 protect the visual apparatus during the development of dopamine-2 receptor knockout mouse model of Parkinsonism
  12. Leaf paste of Telfairia occidentalis favourably modulates deleterious effects associated with exposure to diethylnitrosamine in male Wistar rats
  13. Chemical composition, antioxidant, and enzyme inhibitory properties of Rauwolfia vomitoria extract
  14. Intra-stromal injection of honey-treated keratocytes as a cell-based therapy for experimental corneal laceration
  15. Effect of Annona squamosa leaf extract on human promyelocytic leukemia cells subjected to oxidative stress
  16. Cinnamic acids as promising bioactive compounds for cancer therapy by targeting MAPK3: a computational simulation study
  17. Cowanin induces apoptosis in breast cancer cells via Bcl-2 signaling pathway
  18. Arq Ajīb – a wonder Unani formulation for inhibiting SARS-CoV-2 spike glycoprotein and main protease – an in silico approach
  19. Immediate effect of a meditation technique on blood glucose, state anxiety and relaxation in patients with type 2 diabetes: a pilot randomized crossover study
  20. Effect of moderate intensity resistance training with blood flow restriction on muscle strength and girth in young adults – a randomized control trial
  21. Short Communication
  22. Icosapent ethyl (VASCEPA®) as treatment for post-acute sequelae of SARS CoV-2 (PASC) vaccine induced injury and infection
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2023-0053/html
Scroll to top button